The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think you are right ... good science, good efficacy, good timing ... but poor managerial oversight
Soupdragon78.
I like that kind of optimism .... you never know!
Twitter p&d guys pumping again, will see if it's another false dawn, news must be close though so all good.
On the rise, hands up who's nearly at breakeven!
Looks like there will be some late reported buying, volume and price rising.
fingers crossed!
Aberdeenman
The below just shows the sort of opportunity that is out there.
Roche has agreed to pay $390 million up front, plus another $1 billion in further payments when certain development, regulatory,m and sales milestones are achieved.
https://pharmaphorum.com/news/roche-looks-to-increase-ipf-presence-with-1-39bn-promedior-buy/
Remember Roche last year bought up Promedior and their IPF treatment for $1.39bn.
Thats the landscape.
(Crikey, that was optimistic for me to post!)
On the move again (northwards), volume suddenly picking up.
Aberdeenman
ForFXsake,
They have looked at licensing models before, get an upfront payment, then license for geographical areas, it then becomes a huge valuation on p/e multiples, as NFX is in effect a cash cow with very low overheads.
If they sell the IP, I only hope it is for a truly significant sum, bit like selling the family farm, you would only do it if the offer is very lucrative as it takes away the potential for future earnings.
Aberdeenman
To be honest I don't give a monkies if we "hire" a ceo or not.
All I'm interested in is just some of this last years rhetoric from NFX to come to fruition.
Aberdeenman- Thanks and a good point. I also didn't look at it that way with a deal first before ceo and id actually prefer that route now tbh.
I would like to see a CEO appointment ASAP to show that they have a plan that they are working to. They said they needed a CEO to drive things forward, ergo things are not going to move to quickly without one. I was rather hoping they were a couple of steps ahead on that and would have an RNS quickly the placing was finalised.
With regards to theories about this being a 100 bagger, I thought the NFX strategy was to build up a portfolio and then sell it on. If they don't plan to develop in house then is that really feasible? Would they not just get taken out sooner?
To be honest, I'd be happy be to just see it 2 bag at the moment.
Agree once a deal is finally done NFX will become an absolute beast with all that cash coming in, patience wearing thin but the potential upside is absolutely massive from this mcap
Aberdeenman- Fair point. I didn't look at it that way (deal before ceo) . But makes sense either way. Let's see what happens.
difficult to say Scary. CB is an unknown quantity, we know he has built a $B pharma enterprise before.
He may want to get the deal done, and get a higher flying CEO in to ride it up.
NFX becomes a different beast with a deal done, we know there is interest in NPX002 already, and we know deals are being done elsewhere on Covid related treatments, it is only a matter of time.
I think we will find out sooner rather than later.
Aberdeenman
Scaryone-I would also expect the Ceo news first, as that seems the logical step. I wouldn't like to second CB and NFX however ??
So what do people expect to come first? New CEO or other news? Personally I would have thought a new CEO first so he can build confidence by releasing news/deals
Agreed Aberdeenman...This is a massive massive market now that we are looking at Covid treatment for long term sufferers. It's a great pity it fell over with the Chinese deal. I think it was down to timing and strategy. I am surprised that we haven't heard much on NXP002. I am still hopeful of the kissei deal. Time will tell and it will soar if this deal is struck. GLA.
Not saying 100 bagger any time soon Scary, but a 10 bagger on a deal is feasable, and as I said, over time then p to those giddy heights.
The model NFX has, with ultra low overheads mean stellar margins. a licensing model, they have a global market and with Covid treatment this is now a much much bigger market.
Aberdeenman
yes we are a low 3.5p...I would be happy when we are in double figures once again...think about 14p hit at the top of the share performance (long while back though).
Yes i could..that was the max its reached I believe. But I am an LTH so waiting for the 20-40p mark as an initial assessment!
Aberdeenman- I agree with the 10 bag soon but do you realise a 100 bag would value Nfx at a whopping 1.6 billion mcap.... obviously I’d be more than happy but we are only a crappy 3.5p atm
15p? way too low for when a deal is done.
Got to realise where this is going, this has 100 bagger written all over it, not saying overnight, but 10 bagger on deal news then another 10x after that.
I will be accused of ramping, but have said the same when there were no new investors around.
If you saw the deal I posted yesterday for VELA, which I am not in nor plugging, it shows the kind of size of investment and possible returns that can be expected.
Aberdeenman
Cheers Ganners, there must be a lot like us. When, if good news hits it will be especially satisfying. GLA
Sorry to here you bought on the rise Thompi. Don't worry I am sure you will reap the benefits in the long term! I have been sitting on mine for around 2-3 years now...and still waiting.